Clinical Trial Update: Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating enhanced systemic therapy combined with local treatment for primary and metastatic lesions in oligometastatic prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Fudan University | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN